Skip to main content
Log in

Nephrotoxins and nephrotoxic acute kidney injury

  • Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Although the concept of nephrotoxicity has been recognized for more than 80 years, interest in nephrotoxins has intensified dramatically over the past two decades. Much of this attention has rightfully been focused on pharmaceutical agents and iatrogenic harm; however, it is important for providers to recognize that nephrotoxins can be found in naturally occurring substances as well. Although nephrotoxins exist in a myriad of forms, the means by which they induce injury can be organized into a few categories. For most of these agents, regardless of the mechanism, the final common pathway is acute kidney injury (AKI). Unfortunately, therapeutic options are limited and no treatments currently exist to reverse nephrotoxic AKI once it occurs. As a result, current strategies focus on increased awareness, nephrotoxin avoidance, early injury detection, and mitigation of disease severity. The goal of this review is to summarize our current understanding of nephrotoxic mechanisms and the epidemiology of nephrotoxic AKI. Additionally, avoidance and preventative strategies are discussed, screening approaches are suggested, and chronic monitoring recommendations are made.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Schreiner GE (1965) Toxic nephropathy: adverse renal effects caused by drugs and chemicals. JAMA 191:849–850

    Article  CAS  Google Scholar 

  2. Balter P, Muehrcke RC, Morris AM, Moles JB, Lawrence AG (1976) Chronic toxic nephropathies--diagnosis and management. Ann Clin Lab Sci 6:306–311

    CAS  PubMed  Google Scholar 

  3. Kleinknecht D, Landais P, Goldfarb B (1987) Drug-associated acute renal failure. A prospective collaborative study of 81 biopsied patients. Adv Exp Med Biol 212:125–128

    Article  CAS  Google Scholar 

  4. Kleinknecht D, Landais P, Goldfarb B (1986) Analgesic and non-steroidal anti-inflammatory drug-associated acute renal failure: a prospective collaborative study. Clin Nephrol 25:275–281

    CAS  PubMed  Google Scholar 

  5. Thomas MC (2000) Diuretics, ACE inhibitors and NSAIDs--the triple whammy. Med J Aust 172:184–185

    Article  CAS  Google Scholar 

  6. Moffett BS, Goldstein SL (2011) Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol 6:856–863. https://doi.org/10.2215/CJN.08110910

    Article  PubMed  PubMed Central  Google Scholar 

  7. Schetz M, Dasta J, Goldstein S, Golper T (2005) Drug-induced acute kidney injury. Curr Opin Crit Care 11:555–565

    Article  Google Scholar 

  8. Gupta N, Gibson M, Wallace EC (2019) Lithium-induced chronic kidney disease in a pediatric patient. Case Rep Pediatr 2019:5406482. https://doi.org/10.1155/2019/5406482

    Article  PubMed  PubMed Central  Google Scholar 

  9. Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D’Agati VD (2000) Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11:1439–1448

    CAS  PubMed  Google Scholar 

  10. Pape L, Ahlenstiel T (2014) mTOR inhibitors in pediatric kidney transplantation. Pediatr Nephrol 29:1119–1129. https://doi.org/10.1007/s00467-013-2505-9

    Article  PubMed  Google Scholar 

  11. KDIGO AKI Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:1–138

    Article  Google Scholar 

  12. Abuelo JG (1990) Renal failure caused by chemicals, foods, plants, animal venoms, and misuse of drugs. An overview. Arch Intern Med 150:505–510

    Article  CAS  Google Scholar 

  13. Neto MM, Silva GEB, Costa RS, Vieira Neto OM, Garcia-Cairasco N, Lopes NP, Haendchen PFC, Silveira C, Mendes AR, Filho RR, Dantas M (2009) Star fruit: simultaneous neurotoxic and nephrotoxic effects in people with previously normal renal function. NDT Plus 2:485–488. https://doi.org/10.1093/ndtplus/sfp108

    Article  PubMed  PubMed Central  Google Scholar 

  14. Soderland P, Lovekar S, Weiner DE, Brooks DR, Kaufman JS (2010) Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis 17:254–264. https://doi.org/10.1053/j.ackd.2010.03.011

    Article  PubMed  Google Scholar 

  15. Nanavati A, Herlitz LC (2017) Tubulointerstitial injury and drugs of abuse. Adv Chronic Kidney Dis 24:80–85. https://doi.org/10.1053/j.ackd.2016.09.008

    Article  PubMed  Google Scholar 

  16. Goldstein SL, Kirkendall E, Nguyen H, Schaffzin JK, Bucuvalas J, Bracke T, Seid M, Ashby M, Foertmeyer N, Brunner L, Lesko A, Barclay C, Lannon C, Muething S (2013) Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 132:e756–e767. https://doi.org/10.1542/peds.2013-0794

    Article  PubMed  Google Scholar 

  17. Basu RK, Kaddourah A, Terrell T, Mottes T, Arnold P, Jacobs J, Andringa J, Goldstein SL, Prospective Pediatric AKI Research Group (ppAKI) (2015) Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study. BMC Nephrol 16:24. https://doi.org/10.1186/s12882-015-0016-6

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hoste EAJ, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honoré PM, Joannes-Boyau O, Joannidis M, Korhonen A-M, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA (2015) Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 41:1411–1423. https://doi.org/10.1007/s00134-015-3934-7

    Article  PubMed  Google Scholar 

  19. McGregor TL, Jones DP, Wang L, Danciu I, Bridges BC, Fleming GM, Shirey-Rice J, Chen L, Byrne DW, Van Driest SL (2016) Acute kidney injury incidence in noncritically ill hospitalized children, Adolescents, and young adults: a retrospective observational study. Am J Kidney Dis 67:384–390. https://doi.org/10.1053/j.ajkd.2015.07.019

    Article  PubMed  Google Scholar 

  20. Goldstein SL (2017) Nephrotoxicities. F1000Res 6:55. https://doi.org/10.12688/f1000research.10192.1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Hui-Stickle S, Brewer ED, Goldstein SL (2005) Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45:96–101

    Article  Google Scholar 

  22. McWilliam SJ, Antoine DJ, Smyth RL, Pirmohamed M (2017) Aminoglycoside-induced nephrotoxicity in children. Pediatr Nephrol 32:2015–2025. https://doi.org/10.1007/s00467-016-3533-z

    Article  PubMed  Google Scholar 

  23. Hazlewood KA, Brouse SD, Pitcher WD, Hall RG (2010) Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? Am J Med 123:182.e1–182.e7. https://doi.org/10.1016/j.amjmed.2009.05.031

    Article  CAS  PubMed Central  Google Scholar 

  24. Moffett BS, Morris J, Kam C, Galati M, Dutta A, Akcan-Arikan A (2018) Vancomycin associated acute kidney injury in pediatric patients. PLoS One 13:e0202439. https://doi.org/10.1371/journal.pone.0202439

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Moffett BS, Hilvers PS, Dinh K, Arikan AA, Checchia P, Bronicki R (2015) Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients. Congenit Heart Dis 10:E6–E10. https://doi.org/10.1111/chd.12187

    Article  PubMed  Google Scholar 

  26. Hays WB, Tillman E (2019) Vancomycin-associated acute kidney injury in critically ill adolescent and young adult patients. J Pharm Pract. https://doi.org/10.1177/0897190019829652

  27. Do C (2017) Intravenous contrast: friend or foe? A review on contrast-induced nephropathy. Adv Chronic Kidney Dis 24:147–149. https://doi.org/10.1053/j.ackd.2017.03.003

    Article  PubMed  Google Scholar 

  28. Luk L, Steinman J, Newhouse JH (2017) Intravenous contrast-induced nephropathy-the rise and fall of a threatening idea. Adv Chronic Kidney Dis 24:169–175. https://doi.org/10.1053/j.ackd.2017.03.001

    Article  PubMed  Google Scholar 

  29. Wilhelm-Leen E, Montez-Rath ME, Chertow G (2017) Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 28:653–659. https://doi.org/10.1681/ASN.2016010021

    Article  PubMed  Google Scholar 

  30. Davenport MS, Khalatbari S, Cohan RH, Dillman JR, Myles JD, Ellis JH (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology 268:719–728. https://doi.org/10.1148/radiol.13122276

    Article  Google Scholar 

  31. McDonald RJ, McDonald JS, Carter RE, Hartman RP, Katzberg RW, Kallmes DF, Williamson EE (2014) Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 273:714–725. https://doi.org/10.1148/radiol.14132418

    Article  PubMed  Google Scholar 

  32. Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL, Investigators AWARE (2017) Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 376:11–20. https://doi.org/10.1056/NEJMoa1611391

    Article  Google Scholar 

  33. Zappitelli M, Moffett BS, Hyder A, Goldstein SL (2011) Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study. Nephrol Dial Transplant 26:144–150. https://doi.org/10.1093/ndt/gfq375

    Article  PubMed  Google Scholar 

  34. Sutherland SM, Ji J, Sheikhi FH, Widen E, Tian L, Alexander SR, Ling XB (2013) AKI in hospitalized children: epidemiology and clinical associations in a national cohort. Clin J Am Soc Nephrol 8:1661–1669. https://doi.org/10.2215/CJN.00270113

    Article  PubMed  PubMed Central  Google Scholar 

  35. Askenazi DJ, Feig DI, Graham NM, Hui-Stickle S, Goldstein SL (2006) 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69:184–189. https://doi.org/10.1038/sj.ki.5000032

    Article  CAS  PubMed  Google Scholar 

  36. Mammen C, Al Abbas A, Skippen P, Nadel H, Levine D, Collet JP, Matsell DG (2012) Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis 59:523–530. https://doi.org/10.1053/j.ajkd.2011.10.048

    Article  PubMed  Google Scholar 

  37. Goldstein SL, Devarajan P (2008) Progression from acute kidney injury to chronic kidney disease: a pediatric perspective. Adv Chronic Kidney Dis 15:278–283. https://doi.org/10.1053/j.ackd.2008.04.007

    Article  PubMed  PubMed Central  Google Scholar 

  38. Uber AM, Sutherland SM (2018) Acute kidney injury in hospitalized children: consequences and outcomes. Pediatr Nephrol. https://doi.org/10.1007/s00467-018-4128-7

  39. Uber AM, Montez-Rath ME, Kwiatkowski DM, Krawczeski CD, Sutherland SM (2018) Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery. Pediatr Nephrol 33:2193–2199. https://doi.org/10.1007/s00467-018-4010-7

    Article  PubMed  Google Scholar 

  40. Hayes W (2017) Stop adding insult to injury-identifying and managing risk factors for the progression of acute kidney injury in children. Pediatr Nephrol 32:2235–2243. https://doi.org/10.1007/s00467-017-3598-3

    Article  PubMed  PubMed Central  Google Scholar 

  41. Xu X, Nie S, Zhang A, Mao J, Liu H-P, Xia H, Xu H, Liu Z, Feng S, Zhou W, Liu X, Yang Y, Tao Y, Feng Y, Chen C, Wang M, Zha Y, Feng J-H, Li Q, Ge S, Chen J, He Y, Teng S, Hao C, Liu B-C, Tang Y, He W, He P, Hou FF (2018) Acute kidney injury among hospitalized children in China. Clin J Am Soc Nephrol 13:1791–1800. https://doi.org/10.2215/CJN.00800118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Menon S, Kirkendall ES, Nguyen H, Goldstein SL (2014) Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J Pediatr 165:522–527.e2. https://doi.org/10.1016/j.jpeds.2014.04.058

    Article  CAS  PubMed  Google Scholar 

  43. Jones DP, Spunt SL, Green D, Springate JE, Children’s Oncology Group (2008) Renal late effects in patients treated for cancer in childhood: a report from the Children’s Oncology Group. Pediatr Blood Cancer 51:724–731. https://doi.org/10.1002/pbc.21695

    Article  PubMed  PubMed Central  Google Scholar 

  44. Hanna MH, Askenazi DJ, Selewski DT (2016) Drug-induced acute kidney injury in neonates. Curr Opin Pediatr 28:180–187. https://doi.org/10.1097/MOP.0000000000000311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB, Kirkendall ES (2016) A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 90:212–221. https://doi.org/10.1016/j.kint.2016.03.031

    Article  PubMed  Google Scholar 

  46. Greenberg JH, Parikh CR (2017) Biomarkers for diagnosis and prognosis of AKI in children: one size does not fit all. Clin J Am Soc Nephrol 12:1551–1557. https://doi.org/10.2215/CJN.12851216

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Chawla LS, Bellomo R, Bihorac A, Goldstein SL, Siew ED, Bagshaw SM, Bittleman D, Cruz D, Endre Z, Fitzgerald RL, Forni L, Kane-Gill SL, Hoste E, Koyner J, Liu KD, Macedo E, Mehta R, Murray P, Nadim M, Ostermann M, Palevsky PM, Pannu N, Rosner M, Wald R, Zarbock A, Ronco C, Kellum JA, Acute Disease Quality Initiative Workgroup 16 (2017) Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup. Nat Rev Nephrol 13:241–257. https://doi.org/10.1038/nrneph.2017.2

    Article  PubMed  Google Scholar 

  48. Sutherland SM (2018) Electronic health record-enabled big-data approaches to nephrotoxin-associated acute kidney injury risk prediction. Pharmacotherapy 38:804–812. https://doi.org/10.1002/phar.2150

    Article  PubMed  Google Scholar 

  49. Crona DJ, Faso A, Nishijima TF, McGraw KA, Galsky MD, Milowsky MI (2017) A systematic review of strategies to prevent cisplatin-induced nephrotoxicity. Oncologist 22:609–619. https://doi.org/10.1634/theoncologist.2016-0319

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Izzedine H, Launay-Vacher V, Deray G (2005) Antiviral drug-induced nephrotoxicity. Am J Kidney Dis 45:804–817. https://doi.org/10.1053/j.ajkd.2005.02.010

    Article  CAS  PubMed  Google Scholar 

  51. Karimzadeh I, Farsaei S, Khalili H, Dashti-Khavidaki S (2012) Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity? Expert Opin Drug Saf 11:969–983. https://doi.org/10.1517/14740338.2012.721775

    Article  CAS  PubMed  Google Scholar 

  52. Askenazi DJ, Koralkar R, Hundley HE, Montesanti A, Patil N, Ambalavanan N (2013) Fluid overload and mortality are associated with acute kidney injury in sick near-term/term neonate. Pediatr Nephrol 28:661–666. https://doi.org/10.1007/s00467-012-2369-4

    Article  PubMed  Google Scholar 

  53. Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, Hackbarth R, Somers MJG, Baum M, Symons JM, Flores FX, Benfield M, Askenazi D, Chand D, Fortenberry JD, Mahan JD, McBryde K, Blowey D, Goldstein SL (2010) Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis 55:316–325. https://doi.org/10.1053/j.ajkd.2009.10.048

    Article  PubMed  Google Scholar 

  54. Muttath A, Annayappa Venkatesh L, Jose J, Vasudevan A, Ghosh S (2019) Adverse outcomes due to aggressive fluid resuscitation in children: a prospective observational study. J Pediatr Intensive Care 8:64–70. https://doi.org/10.1055/s-0038-1667009

    Article  PubMed  Google Scholar 

  55. McMahon K, Zappitelli M (2016) Aminophylline for acute kidney injury after pediatric cardiac surgery: finally entering the next phase in child acute kidney injury research. Pediatr Crit Care Med 17:170–171. https://doi.org/10.1097/PCC.0000000000000631

    Article  PubMed  Google Scholar 

  56. Bhatt GC, Gogia P, Bitzan M, Das RR (2019) Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic review. Arch Dis Child 104:670–679. https://doi.org/10.1136/archdischild-2018-315805

    Article  PubMed  Google Scholar 

  57. Axelrod DM, Anglemyer AT, Sherman-Levine SF, Zhu A, Grimm PC, Roth SJ, Sutherland SM (2014) Initial experience using aminophylline to improve renal dysfunction in the pediatric cardiovascular ICU. Pediatr Crit Care Med 15:21–27. https://doi.org/10.1097/01.pcc.0000436473.12082.2f

    Article  PubMed  Google Scholar 

  58. McLaughlin GE, Abitbol CL (2005) Reversal of oliguric tacrolimus nephrotoxicity in children. Nephrol Dial Transplant 20:1471–1475. https://doi.org/10.1093/ndt/gfh785

    Article  CAS  PubMed  Google Scholar 

  59. Su X, Xie X, Liu L, Lv J, Song F, Perkovic V, Zhang H (2017) Comparative effectiveness of 12 treatment strategies for preventing contrast-induced acute kidney injury: a systematic review and Bayesian Network meta-analysis. Am J Kidney Dis 69:69–77. https://doi.org/10.1053/j.ajkd.2016.07.033

    Article  CAS  PubMed  Google Scholar 

  60. Solomon RJ (2014) Antioxidant therapy with N-acetylcysteine for contrast-induced acute kidney injury: a final nail in the coffin? Coron Artery Dis 25:94–95. https://doi.org/10.1097/MCA.0000000000000076

    Article  PubMed  Google Scholar 

  61. Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin S-S, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, EO MF, Brophy M, Ferguson R, Wu H, Androsenko M, Myles J, Kaufman J, Palevsky PM, PRESERVE Trial Group (2018) Outcomes after angiography with sodium bicarbonate and acetylcysteine. N Engl J Med 378:603–614. https://doi.org/10.1056/NEJMoa1710933

    Article  CAS  PubMed  Google Scholar 

  62. Shimizu MHM, Gois PHF, Volpini RA, Canale D, Luchi WM, Froeder L, Heilberg IP, Seguro AC (2017) N-acetylcysteine protects against star fruit-induced acute kidney injury. Ren Fail 39:193–202. https://doi.org/10.1080/0886022X.2016.1256315

    Article  CAS  PubMed  Google Scholar 

  63. Huang S, You J, Wang K, Li Y, Zhang Y, Wei H, Liang X, Liu Y (2019) N-acetylcysteine attenuates cisplatin-induced acute kidney injury by inhibiting the C5a receptor. Biomed Res Int 2019:4805853. https://doi.org/10.1155/2019/4805853

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Amini S, Robabi HN, Tashnizi MA, Vakili V (2018) Selenium, vitamin C and N-acetylcysteine do not reduce the risk of acute kidney injury after off-pump CABG: a randomized clinical trial. Braz J Cardiovasc Surg 33:129–134. https://doi.org/10.21470/1678-9741-2017-0071

    Article  PubMed  PubMed Central  Google Scholar 

  65. He G, Li Q, Li W, Wang L, Yang J, Zeng F (2018) N-acetylcysteine for preventing of acute kidney injury in chronic kidney disease patients undergoing cardiac surgery: a metaanalysis. Heart Surg Forum 21:E513–E521. https://doi.org/10.1532/hsf.2193

    Article  PubMed  Google Scholar 

  66. Leino K, Hynynen M, Jalonen J, Salmenperä M, Scheinin H, Aantaa R, Dexmedetomidine in Cardiac Surgery Study Group (2011) Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiol 11:9. https://doi.org/10.1186/1471-2253-11-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Ji F, Li Z, Young JN, Yeranossian A, Liu H (2013) Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS One 8:e77446. https://doi.org/10.1371/journal.pone.0077446

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Balkanay OO, Goksedef D, Omeroglu SN, Ipek G (2015) The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg 20:209–214. https://doi.org/10.1093/icvts/ivu367

    Article  PubMed  Google Scholar 

  69. Kwiatkowski DM, Axelrod DM, Sutherland SM, Tesoro TM, Krawczeski CD (2016) Dexmedetomidine is associated with lower incidence of acute kidney injury after congenital heart surgery. Pediatr Crit Care Med 17:128–134. https://doi.org/10.1097/PCC.0000000000000611

    Article  PubMed  Google Scholar 

  70. Benoit SW, Goldstein SL, Dahale DS, Haslam DB, Nelson A, Truono K, Davies SM (2019) Reduction in nephrotoxic antimicrobial exposure decreases associated acute kidney injury in pediatric hematopoietic stem cell transplant patients. Biol Blood Marrow Transplant 25:1654–1658. https://doi.org/10.1016/j.bbmt.2019.04.022

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amanda M. Uber.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uber, A.M., Sutherland, S.M. Nephrotoxins and nephrotoxic acute kidney injury. Pediatr Nephrol 35, 1825–1833 (2020). https://doi.org/10.1007/s00467-019-04397-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-019-04397-2

Keywords

Navigation